American Journal of Obstetrics & Gynecology
Volume 193, Issue 3, Supplement , Pages 1121-1126, September 2005

Fetal immune response to oral pathogens and risk of preterm birth

  • Kim A. Boggess, MD

      Affiliations

    • Department of Obstetrics and Gynecology, University of North Carolina School of Medicine
    • University of North Carolina School of Dentistry
    • Corresponding Author InformationReprints not available from the authors. Address correspondence to Kim A. Boggess, MD, Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, University of North Carolina School of Medicine, Campus Box 7516, Chapel Hill, NC 27599-7516.
  • ,
  • Kevin Moss

      Affiliations

    • Department of Dental Ecology, and Center for Oral and Systemic Diseases
    • University of North Carolina School of Dentistry
  • ,
  • Phoebus Madianos, PhD

      Affiliations

    • University of North Carolina School of Dentistry
  • ,
  • Amy P. Murtha, MD

      Affiliations

    • Department of Obstetrics and Gynecology, Duke University Medical Center, Chapel Hill, NC
  • ,
  • James Beck, PhD

      Affiliations

    • Department of Dental Ecology, and Center for Oral and Systemic Diseases
    • University of North Carolina School of Dentistry
  • ,
  • Steven Offenbacher, DDS, PhD

      Affiliations

    • Department of Dental Ecology, and Center for Oral and Systemic Diseases
    • University of North Carolina School of Dentistry

Received 25 February 2005; received in revised form 9 May 2005; accepted 10 May 2005.

Objective

The purpose of this study was to determine the relationship between fetal inflammatory and immune responses to oral pathogens and risk for preterm birth.

Study design

Six hundred and forty umbilical cord blood specimens were prospectively collected. Cord serum levels of C-reactive protein, interleukin (IL)-1β, IL-6, tumor necrosis factor (TNF)-α, Prostaglandin E2, and 8-isoprostane were determined by enzyme-linked immunosorbent assay and categorized as>median (high) versus ≤ median (low). Presence of fetal immunoglobulin M (IgM) antibody against oral pathogens was determined by checkerboard immunoblot assay; detection of ≥1 oral pathogen specific antibody was categorized as positive. Preterm birth was defined as spontaneous delivery at <35 weeks. Chi-square analysis was used to determine association between cord serum mediator or IgM category and preterm birth. Odds ratios (OR) for preterm birth were calculated, stratified by mediator and IgM category.

Results

Of 640 births, 48 (7.5%) delivered preterm. Preterm birth rates were higher if categorized as high versus low 8-isoprostane or TNF-α (23 vs 5%, P < .001 and 10 vs 4%, P < .01, respectively). Preterm birth rates were also higher if categorized as IgM positive versus negative (10.6 vs 5.8%, P=.04). The joint effects of fetal IgM seropositivity, detectable C-reactive protein, or high 8-isoprostane, PGE2, or TNF-α resulted in significantly increased risk for preterm birth (adjusted OR [95% CI]: 6.0 [2.2-16.5], 4.3 [1.6-11.5], 4.1 [1.5-11.6], and 7.6 [2.3-20.8], respectively).

Conclusion

Fetal exposure to oral pathogens evidenced by an IgM response is associated with preterm birth, and the risk for preterm birth is greatest among fetuses that also demonstrate an inflammatory response.

Key words: Fetal immune response, Periodontal disease, Inflammation

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported by K08 HD043284 (K. A. B.), R01 DE12453 (S. O.), and the University of North Carolina General Clinical Research Center grant RR00046.Presented at the Twenty-Fifth Annual Meeting of the Society for Maternal Fetal Medicine, February 7-12, 2005, Reno, Nev.

PII: S0002-9378(05)00729-5

doi:10.1016/j.ajog.2005.05.050

American Journal of Obstetrics & Gynecology
Volume 193, Issue 3, Supplement , Pages 1121-1126, September 2005